Literature DB >> 27629686

Treatment of lower urinary tract symptoms in benign prostatic hypertrophy with α-blockers.

Mathieos Belayneh1, Christina Korownyk2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27629686      PMCID： PMC5023361     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  12 in total

Review 1.  Lifestyle and lower urinary tract symptoms: what is the correlation in men?

Authors:  Pao-Hwa Lin; Stephen J Freedland
Journal:  Curr Opin Urol       Date:  2015-01       Impact factor: 2.309

2.  Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).

Authors:  J Curtis Nickel; Peter Gilling; Teuvo L Tammela; Betsy Morrill; Timothy H Wilson; Roger S Rittmaster
Journal:  BJU Int       Date:  2011-06-01       Impact factor: 5.588

3.  2010 Update: Guidelines for the management of benign prostatic hyperplasia.

Authors:  J Curtis Nickel; Carlos E Méndez-Probst; Thomas F Whelan; Ryan F Paterson; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

4.  Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies.

Authors:  C G Roehrborn; P Van Kerrebroeck; J Nordling
Journal:  BJU Int       Date:  2003-08       Impact factor: 5.588

5.  Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

Authors:  M J Barry; W O Williford; Y Chang; M Machi; K M Jones; E Walker-Corkery; H Lepor
Journal:  J Urol       Date:  1995-11       Impact factor: 7.450

6.  Comparative Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Network Meta-analysis.

Authors:  Jin-Qiu Yuan; Chen Mao; Samuel Yeung-Shan Wong; Zu-Yao Yang; Xiao-Hong Fu; Xiao-Yu Dai; Jin-Ling Tang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 7.  A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia.

Authors:  J C Nickel; S Sander; T D Moon
Journal:  Int J Clin Pract       Date:  2008-10       Impact factor: 2.503

Review 8.  Finasteride for benign prostatic hyperplasia.

Authors:  James Tacklind; Howard A Fink; Roderick Macdonald; Indy Rutks; Timothy J Wilt
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

9.  The effect of complete transurethral resection of the prostate on symptoms, quality of life, and voiding function improvement.

Authors:  Daimantas Milonas; Jone Verikaite; Mindaugas Jievaltas
Journal:  Cent European J Urol       Date:  2015-03-31

10.  The risk of fall and fracture with the initiation of a prostate-selective α antagonist: a population based cohort study.

Authors:  Blayne Welk; Eric McArthur; Lisa-Ann Fraser; Jade Hayward; Stephanie Dixon; Y Joseph Hwang; Michael Ordon
Journal:  BMJ       Date:  2015-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.